Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Change in Account Payables (2023 - 2025)

Historic Change in Account Payables for SeaStar Medical Holding (ICUCW) over the last 3 years, with Q3 2025 value amounting to -$1.1 million.

  • SeaStar Medical Holding's Change in Account Payables fell 8905.47% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year increase of 503.93%. This contributed to the annual value of -$1.3 million for FY2024, which is 15239.26% down from last year.
  • SeaStar Medical Holding's Change in Account Payables amounted to -$1.1 million in Q3 2025, which was down 8905.47% from -$239000.0 recorded in Q2 2025.
  • SeaStar Medical Holding's 5-year Change in Account Payables high stood at $1.3 million for Q2 2023, and its period low was -$1.1 million during Q3 2025.
  • Moreover, its 3-year median value for Change in Account Payables was -$239000.0 (2025), whereas its average is $12363.6.
  • The largest annual percentage gain for SeaStar Medical Holding's Change in Account Payables in the last 5 years was 17119.68% (2025), contrasted with its biggest fall of 20042.02% (2025).
  • Over the past 3 years, SeaStar Medical Holding's Change in Account Payables (Quarter) stood at -$670000.0 in 2023, then surged by 36.87% to -$423000.0 in 2024, then plummeted by 169.5% to -$1.1 million in 2025.
  • Its Change in Account Payables stands at -$1.1 million for Q3 2025, versus -$239000.0 for Q2 2025 and $351000.0 for Q1 2025.